Blood Transfusion Research Centre, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran.
Blood Transfus. 2013 Jul;11(3):385-90. doi: 10.2450/2012.0031-12. Epub 2012 Oct 10.
Haemoglobin screening methods need to be highly sensitive to detect both low and high haemoglobin levels and avoid unnecessary rejection of potential blood donors. The aim of this study was to evaluate the accuracy of measurements by HemoCue in blood donors.
Three hundred and fourteen randomly selected, prospective blood donors were studied. Single fingerstick blood samples were obtained to determine the donors' haemoglobin levels by HemoCue, while venous blood samples were drawn for measurement of the haemoglobin level by both HemoCue and an automated haematology analyser as the reference method. The sensitivity, specificity, predictive values and correlation between the reference method and HemoCue were assessed. Cases with a haemoglobin concentration in the range of 12.5-17.9 g/dL were accepted for blood donation.
Analysis of paired results showed that haemoglobin levels measured by HemoCue were higher than those measured by the reference method. There was a significant correlation between the reference method and HemoCue for haemoglobin levels less than 12.5 g/dL. The correlation was less strong for increasing haemoglobin levels. Linear correlation was poor for haemoglobin levels over 18 g/dL. Thirteen percent of donors, who had haemoglobin levels close to the upper limit, were unnecessarily rejected.
HemoCue is suitable for screening for anaemia in blood donors. Most donors at Yazd are males and a significant percentage of them have haemoglobin values close to the upper limit for acceptance as a blood donor; since these subjects could be unnecessarily rejected on the basis of HemoCue results and testing with this method is expensive, it is recommended that qualitative methods are used for primary screening and accurate quantitative methods used in clinically suspicious cases or when qualitative methods fail.
血红蛋白筛选方法需要高度敏感,以检测低和高血红蛋白水平,并避免不必要地拒绝潜在的献血者。本研究的目的是评估 HemoCue 在献血者中的测量准确性。
随机选择了 314 名献血者进行研究。采集单指血样,用 HemoCue 测定献血者的血红蛋白水平,同时抽取静脉血样,用 HemoCue 和自动血液分析仪测定血红蛋白水平作为参考方法。评估了参考方法和 HemoCue 之间的灵敏度、特异性、预测值和相关性。血红蛋白浓度在 12.5-17.9 g/dL 范围内的病例被接受献血。
配对结果分析表明,HemoCue 测定的血红蛋白水平高于参考方法。对于血红蛋白水平低于 12.5 g/dL 的病例,参考方法和 HemoCue 之间存在显著相关性。随着血红蛋白水平的增加,相关性减弱。对于血红蛋白水平超过 18 g/dL 的病例,线性相关性较差。接近上限的 13%的献血者被不必要地拒绝。
HemoCue 适用于献血者的贫血筛查。亚兹德的大多数献血者为男性,其中相当一部分人的血红蛋白值接近接受献血的上限;由于这些人可能会因 HemoCue 结果而被不必要地拒绝,而且这种方法的检测费用较高,因此建议使用定性方法进行初步筛查,并在临床可疑病例或定性方法失败时使用准确的定量方法。